Margaret von Mehren

Professor

Fox Chase Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Margaret von Mehren is a faculty member at the Fox Chase Cancer Center in the United States. Her research areas focus on gastrointestinal stromal tumors, sarcomas, and melanoma, as evidenced by her recent publications. Notable works include analyses of treatment outcomes with ripretinib and sunitinib, improvements in care for dermatofibrosarcoma protuberans, and the immune landscape in various sarcoma subtypes.

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Elizabeth Montgomery

Professor of Pathology

University of Miami Hospital

UNITED STATES

View details

Michael C. Heinrich

UNITED STATES

View details

Jonathan C. Trent

University of Miami Miller School of Medicine

UNITED STATES

View details

VINOD RAVI

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Hans Gelderblom

Prof.dr.

Leiden University Medical Center

NETHERLANDS

View details

Sebastian Bauer

Professor / Chair

Universität Duisburg-Essen

GERMANY

View details

Jean-Yves Blay

University Professor, Medical Oncology

Université Claude Bernard Lyon 1 - Domaine de Rockefeller

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Margaret von Mehren

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

DNA Damage Repair Pathway Alterations and Immune Landscape Differences in Pediatric/Adolescent, Young Adult (AYA) and Adult Sarcomas

Updated Overall Survival and Long-Term Safety With Ripretinib Versus Sunitinib in Patients With GI Stromal Tumor: Final Overall Survival Analysis From INTRIGUE

Large-Scale Multiomic Analysis Identifies Anatomic Differences and Immunogenic Potential in Subtypes of Leiomyosarcoma

Current patterns of care and outcomes for dermatofibrosarcoma protuberans: An international multi‐institutional collaborative

Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial.

Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trial

Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study.

Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial

OER‐073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma

Gastrointestinal Stromal Tumors: What Is the Best Sequence of TKIs?

Phase II Study of Ponatinib in Advanced Gastrointestinal Stromal Tumors: Efficacy, Safety, and Impact of Liquid Biopsy and Other Biomarkers

Clinical efficacy comparison of avapritinib with other tyrosine kinase inhibitors in gastrointestinal stromal tumors with PDGFRA D842V mutation: a retrospective analysis of clinical trial and real-world data

Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study

Ripretinib intrapatient dose escalation after disease progression provides clinically meaningful outcomes in advanced gastrointestinal stromal tumour

Combined Inhibition of AKT and KIT Restores Expression of Programmed Cell Death 4 (PDCD4) in Gastrointestinal Stromal Tumor

Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer

Collaborators (7)

Elizabeth Montgomery

Michael C. Heinrich

Jonathan C. Trent

VINOD RAVI

Hans Gelderblom

Sebastian Bauer

Jean-Yves Blay

Make your next move.